January 31, 2014
Novartis AG hit Hisamitsu Pharmaceutical Co. Inc. and subsidiary Noven Pharmaceuticals Inc. with a suit in Delaware federal court Thursday, claiming Noven's proposed generic version of the Exelon patch, used to treat dementia, infringes patents covering the drug.